Immvira Stock

Immvira’s scientific objectives are based on numerous experimental designs of oHSV and outcomes of clinical trials.

Sign up today and learn more about Immvira Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Immvira Stock

Immvira was founded in Shenzhen China in May of 2015 by Prof. Bernard Roizman of University of Chicago and Prof. Grace Zhou formerly a Research Associate Professor at University of Chicago, Prof. Thomas Shenk of Princeton University, Prof. Richard Whitley of University of Alabama, Prof. Ralph Weichselbaum of University of Chicago.

Funding History

September 2016$50.0M
January 2019$15.0M
June 2020$58.0M
September 2020$10.0M
September 2022$8.0M



Carl Yeung

CEO/CSO & Founder

Grace Zhou

Chief Medical Officer

Oliver Kong


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: